Canada markets closed

Xenon Pharmaceuticals Inc. (XENE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
43.75+0.75 (+1.74%)
At close: 04:00PM EDT
43.75 0.00 (0.00%)
After hours: 05:29PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-182,393
-182,393
-125,373
-78,882
-28,837
Depreciation & amortization
3,541
3,541
1,624
906
644
Deferred income taxes
-292
-292
-44
58
-285
Stock based compensation
32,372
32,372
20,376
10,017
5,677
Change in working capital
5,635
5,635
-676
-2,647
-26,089
Accounts receivable
130
130
1,757
-459
-1,032
Other working capital
-150,944
-150,944
-101,324
-71,552
-50,761
Other non-cash items
-
-
-
-
216
Net cash provided by operating activites
-145,327
-145,327
-98,430
-69,502
-48,124
Cash flows from investing activities
Investments in property, plant and equipment
-5,617
-5,617
-2,894
-2,050
-2,637
Purchases of investments
-793,907
-793,907
-551,137
-389,474
-228,897
Sales/Maturities of investments
682,354
682,354
258,028
144,754
214,710
Net cash used for investing activites
-117,170
-117,170
-296,003
-246,770
-16,824
Cash flows from financing activities
Debt repayment
-
-
0
0
-16,743
Common stock issued
353,487
353,487
277,766
447,283
102,456
Net cash used privided by (used for) financing activities
353,522
353,522
278,471
447,543
85,795
Net change in cash
91,401
91,401
-118,446
130,679
20,254
Cash at beginning of period
57,242
57,242
175,688
45,009
24,755
Cash at end of period
148,643
148,643
57,242
175,688
45,009
Free Cash Flow
Operating Cash Flow
-145,327
-145,327
-98,430
-69,502
-48,124
Capital Expenditure
-5,617
-5,617
-2,894
-2,050
-2,637
Free Cash Flow
-150,944
-150,944
-101,324
-71,552
-50,761